India to make a pitch on various aspects of Covid-19 management at G7 meet

The G7 summit will be attended by Prime Minister Narendra Modi virtually

G7 Summit
Police officers are seen in front of Carbis Bay Hotel ahead of the G7 summit, in Carbis Bay, Cornwall, Britain | Photo: Reuters
Shreya Nandi New Delhi
2 min read Last Updated : Jun 10 2021 | 6:09 AM IST
India is likely to make a pitch on various aspects of Covid-19 management, such as tackling challenges created by the pandemic globally, and the nation's participation in supplying vaccines in future, at the Group of Seven (G7) summit.
 
A senior government official said India may take up various aspects of the pandemic, including vaccines, building resilient supply chains, as well as a post-recovery road map.
 
The G7 summit will be attended by Prime Minister Narendra Modi virtually.
 
The United Kingdom (UK) is hosting a summit at Cornwall, where seven of the world’s most powerful countries - the UK, the US, Canada, France, Germany, Italy, and Japan - will come together to thrash out a global response to the pandemic, trade, climate, among other challenges.
 
UK Prime Minister Boris Johnson has invited leaders from Australia, India, South Africa, and South Korea to join the summit this year.
 
This is the first meeting of the member countries since the outbreak of the pandemic. It will take place at a time when several countries continue to battle the deadly virus.
 
While the richer nations are making fair progress in their inoculation drive, the poorer countries continue to struggle with limited access to vaccines.
 
Johnson had recently said he would urge the rest of the leaders at the summit to help vaccinate the world by the end of next year. “We have a responsibility to do everything we can to defeat Covid around the world,” Johnson had said.
 
Foreign Secretary Harsh Vardhan Shringla last week also said India would participate in the process of creating global-scale capacities needed to deal with pandemic-scale challenges. “A number of serious global conversations are underway on this on platforms such as the G7, G20, Quadrilateral Security Dialogue, BRICS, the United Nations, and the World Health Organization,” he had said.
 
The official cited above also said the issue of Trade-Related Intellectual Property Rights waiver on Covid vaccine could be discussed. “However, the issue is primarily being taken up at the World Trade Organization (WTO),” added the official.
Experts expect the pandemic and the global health system to be key areas of discussion at the summit.
 
However, any development on trade-related issues will be keenly watched, they said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusG7 summitNarendra ModiBoris JohnsonCoronavirus Vaccine

Next Story